ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
Author(s): Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JHF, Vossen J, Gratwohl A, Vogelsang GB, vanHouwelingen HC, vanRood JJ
Source: NEW ENGLAND JOURNAL OF MEDICINE    Volume: 334    Issue: 5    Pages: 281-285    Published: FEB 1 1996  
Times Cited: 313     References: 28     
Abstract: Background. Graft-versus-host disease (GVHD) can be a major complication of allogeneic bone marrow transplantation even when the donor and recipient are siblings and share identical major histocompatibility antigens. The explanation may be a mismatch of minor histocompatibility antigens. We previously characterized five minor histocompatibility antigens, HA-1, 2, 3, 4, and 5, that are recognized by T cells in association with the major histocompatibility antigens HLA-A1 and A2.

Methods. We collected peripheral-blood leukocytes from 148 bone marrow recipients and their sibling donors, who were genotypically HLA identical. Fifty pairs were positive for HLA-A1, 117 were positive for HLA-A2, and 19 were positive for both. The pairs were typed with cytotoxic-T-cell clones specific for minor histocompatibility antigens HA-1, 2, 3, 4, and 5.

Results. Mismatches of HA-3 were equally distributed among recipients in whom GVHD developed and those in whom it did not. By contrast, a mismatch of only HA-1 was significantly correlated with GVHD of grade II or higher (odds ratio, infinity; P = 0.02) in adults. One or more mismatches of HA-1, 2, 4, and 5 were also significantly associated with GVHD (odds ratio, infinity; P = 0.006) in adults. These associations were not observed in children.

Conclusions. A mismatch of minor histocompatibility antigen HA-1 can cause GVHD in adult recipients of allogeneic bone marrow from HLA-identical donors. Prospective HA-1 typing may improve donor selection and identify recipients who are at high risk for GVHD. (C) 1996, Massachusetts Medical Society.

Document Type: Article
Language: English
Reprint Address: Goulmy, E (reprint author), UNIV LEIDEN HOSP, DEPT IMMUNOHEMATOL & BLOOD BANK, 2300 RC LEIDEN, NETHERLANDS
Addresses:
1. UNIV LEIDEN HOSP, DEPT HEMATOL, 2300 RC LEIDEN, NETHERLANDS
2. UNIV LEIDEN HOSP, DEPT PEDIAT, 2300 RC LEIDEN, NETHERLANDS
3. UNIV LEIDEN HOSP, DEPT MED STAT, 2300 RC LEIDEN, NETHERLANDS
4. UNIV LEIDEN HOSP, EUROPDONOR FDN, 2300 RC LEIDEN, NETHERLANDS
5. KANTONSSPITAL, DIV HEMATOL, DEPT RES, CH-4031 BASEL, SWITZERLAND
6. JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD USA
Publisher: MASS MEDICAL SOC, 10 SHATTUCK, BOSTON, MA 02115
Subject Category: Medicine, General & Internal
IDS Number: TV695
ISSN: 0028-4793
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo